Literature DB >> 15067332

Calbindin-D28k and calcium sensing receptor cooperate in MCF-7 human breast cancer cells.

Jai Parkash1, Muhammad A Chaudhry, William B Rhoten.   

Abstract

The metastases of breast cancer cells to bone result in osteolysis and release of Ca2+. Ca2+ as a primary signal transducer can regulate the expression patterns of cell signaling systems. The extracellular calcium ion concentration sensing receptor CaR is a 123 kDa G-protein coupled membrane protein that resides within caveolin-rich regions as a dimer. CaR is involved in regulating several cellular processes such as proliferation, differentiation, secretion, and apoptosis. Calbindin-D28k is a 28 kDa high affinity calcium-binding protein and it is involved in regulating the intracellular calcium ion concentration, [Ca2+]i, and thus influences signal transduction. The role of CaR in sensing and responding to extracellular calcium ion concentration, [Ca2+]o, and neomycin sulfate, and spatial interactions of CaR with calbindin-D28k in MCF-7 human breast cancer cells were studied. Fura-2 loaded MCF-7 cells were exposed to increasing concentrations of CaCl2 or neomycin sulfate and the [Ca2+]i was determined by ratio fluorescence microscopy. The step-wise addition of CaCl2 or neomycin sulfate caused an increase in [Ca2+]i. The normalized dose response curves fitting yielded Hill co-efficient values of 4.32+/-0.63 and 1.49+/-0.14 for Ca2+ and neomycin sulfate respectively, thus indicating highly co-operative, 4-5 binding sites for Ca2+ and 1-2 binding site(s) for neomycin sulfate on CaR. The EC50 values were 21+/-1.6 mM and 43+/-3.5 micro M for CaCl2 and neomycin sulfate respectively. The confocal microscopy data, obtained by using a highly sensitive tyramide signal amplification technology for immunofluorescence detection, showed CaR and calbindin-D28k were co-localized when cells were exposed to 200 micro M neomycin sulfate, whereas in control cells there was no co-localization of these two proteins. We hypothesize that sensing and responses to increasing [Ca2+]o that occur through CaR, increase the [Ca2+]i causing the translocation of Ca2+-bound calbindin-D28k towards CaR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067332

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  Calcium-sensing receptor stimulation induces nonselective cation channel activation in breast cancer cells.

Authors:  Yassine El Hiani; Ahmed Ahidouch; Morad Roudbaraki; Stéphanie Guenin; Gérard Brûlé; Halima Ouadid-Ahidouch
Journal:  J Membr Biol       Date:  2006-10-14       Impact factor: 1.843

Review 2.  Calcium signaling and T-type calcium channels in cancer cell cycling.

Authors:  James T Taylor; Xiang-Bin Zeng; Jonathan E Pottle; Kevin Lee; Alun R Wang; Stephenie G Yi; Jennifer A S Scruggs; Suresh S Sikka; Ming Li
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

Review 3.  Calcium-sensing receptor in cancer: good cop or bad cop?

Authors:  Bandana Chakravarti; Shailendra Kumar Dhar Dwivedi; Ambrish Mithal; Naibedya Chattopadhyay
Journal:  Endocrine       Date:  2008-11-15       Impact factor: 3.633

Review 4.  Cellular calcium dynamics in lactation and breast cancer: from physiology to pathology.

Authors:  Brandie M Cross; Gerda E Breitwieser; Timothy A Reinhardt; Rajini Rao
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-13       Impact factor: 4.249

5.  CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells.

Authors:  Long-Qiao Cao; Ya-Nan Wang; Ming Liang; Mei-Zhou Pan
Journal:  Mol Med Rep       Date:  2019-04-30       Impact factor: 2.952

6.  Manganese-enhanced MRI (MEMRI) in breast and prostate cancers: Preliminary results exploring the potential role of calcium receptors.

Authors:  Gabriella Baio; Marina Fabbi; Michele Cilli; Francesca Rosa; Simona Boccardo; Francesca Valdora; Sandra Salvi; Luca Basso; Laura Emionite; Eliana Gianolio; Silvio Aime; Carlo Emanuele Neumaier
Journal:  PLoS One       Date:  2020-09-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.